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Atherosclerotic cardiovasadar disease is a major health prob- 
kmcausingneariyhalfoftbedeathsintbeAmericanpopu- 
lation. Aithoogh sign&ant eLTorls have been made to deter- 
mine the etiology of this process, only epidemiologic 
assuc*tiomihavebeeafwnd.Aninfectiouscause forcoronary 
arteqdiseasehasbeenpropo&bysomebutiscurrenUynot 
aaeptd However, the rise and fall of tbe incidence of 
coronaryarterydkaaeiatheUnitedStatesfromthe1940s 
tbrotlgbthe1!vosappeaIstoemldatetbatofaninfectious 
epidemic (l-3). Additiomdiy, tbe recent diswwy of Hdico- 
&wtt!rpylopiasIheinfeetiousetiologyof~chronic 
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erosde~~is includes the true incidence of bacterial infection, a 
dinicai correlation with the presence of infection, and the 
kiqueness of the association. If Chkzmy& infection were the 
major cause of axonmy athenxclerosi$ one might expect a 
high iocidem of bacteria detected within the plaque of a 
prapedvely studii series of symptomatic patients. If Chla- 
mydiu infection were only one of g number of possible causes 
of ammary atherosclerosis, the incidence of bacterial detec- 
tion in such a series might be lower, although a signikant 
oxrelation might be found between the presence of Chfumydia 
and certain clinkal characteristics. If the presence of Chlo- 
mydiQ pneunwniae within the atlxrosclerotic plaque Eere 
simply tbe manifestation of an “immcznt bystander,” one 
might also expect the bacteria to be found in other cardiovas- 
cular drsease states as well as coronary atherosclerosis, espe- 
cially those also associated with endothelial disruption. 
The purpose of this study was, therefore, 1) to determine 
the incidence of the CMrunydicr pathogen within atheroscle- 
rotic plaques in a prospectively studied axxecutive series of 
symptomatic American patients requiring coronary revascular- 
i&on using directional axonary atherectomy, 2) to compare 
the dinicai features of those demonstrating the pathogen t0 
thoseno&and3)toc0mparetheincidenceofC&n@a 
m in patients with symptomatic atberaszlerotic car- 
mary dii to that of patients with other forms of cardii 
vascular disease, in&ding cardiac transplant rejection arteri- 
opathy and idiopathic cardiomyopathy. 
WthOdS 
e eoinui. In order to obtain atherosclerok 
ulaauezcimensfroma awrsecutive cohort of natients with . - 
symp+atic mmnmy artery disease, all patie& undergoing 
dtmhcd ammary atherectomy at LDS Hospital between 
January 1993 and July 1994 who gave informed c0nsent were 
inchuM in the study. A total of 90 patients were enrded. 
AU patients were pretreated with aspirin 32.5 mg daily for at 
least24hbeforeathereaomy.Gucomitantmedicaltherapy 
such as beta-adrenergic bloddng agentg calcium channel 
block% tdrates and dipyriQmde were amtinued at the 
discretion of the attending physiin. Athereetomy was per- 
formed via the fenrorpl ap,xoach wing 1OF arterial sheaths 
and guide catheters. Hepat% (lO,tllK~ unit?) was administered 
atthebeginning0feacbprocedureaftervasz&araceesshad 
beenest&Wxkandfurtherheparinw~adminkk~~ 
necessasyduringtheproa&retomaintainanactivated 
clott&timeat~35Os.Adk&onaltr0naryathereuomy 
catheter (sii coronmy Athem Devices for vasar- 
IarIlknaltioo,Inc.)suhablyshedtoproduceanappronhnate 
deviaz4wutery r&i0 of lkl was prepared and advanced 
acmss the lesion over a 0.014-h& 10.36mm) ezhangeable 
guidewkUaingthebwest~dtisibk~pressure,as 
manyatkxWoinycutswerpmadeaswererequiredt0c&ain 
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examination. All,specimeos underwent direct immunofluores- 
cence testing. 
Nonatheruselklc eohurt. In order to provide a variety of 
control specimens %om nonatherosclerotic cardiovascular dis- 
ease processes, pathologic specimens were obtained from a 
number of sources, including 1) normal c0rooary artery tissue 
from 12 patients (3 wiih idiopathic cardiomyopathy, I infant 
with umgcnital heart disease and 8 with traumatic death) 
suffering de&h for reasons other than coronary artery disease, 
and 2) diffusely diseased coronary artery tissue from 12 pa- 
tients with chronic transplant rejection-induced ischemic cor- 
onary heart disease obtained either at autopsy or repeat heart 
traosplantaiion. All specimens were sent for direct immuno- 
fluorescence *estIog. 
Pathology exumlnation. Immunofluorescence. Specimens 
for immuoofl~oresceoce were frozen in OCT, cut at 4 firn onto 
glass slides, and air dried. After 30 ruin, they were layered with 
the test antiMy, obtained prediluted from Baxter Scientific. 
The antibody is a mouse monoclonal antl&ody directed at a 
3,OOO-Da lipoprotein common to all known types of Chlarnydio 
species, tn&omatis,psitfuci andpneumutiae. The antibody has 
been directly conjugated with fluorescein isothiocyanate. Slies 
were washed in phosphate-buffered saline (PBS), incubated 
with the andbody for 30 min in a moist chamber at room 
temperature, and washed three times in PBS before coverslip- 
ping in Aquamount. Slides were reviewed in an epifluorescent 
microscope equipped with filter combination to detect fluores- 
cein isothiocyanate. Positive and negative slides were photo- 
graphed using ASA 64O film with manual exposure times of 
15 s. Positive and negative con&ols were nm with each batch of 
test slides. These Lomisted of the antigen controls received 
with the ant~kly, ahich were monkey kidney cells infected 
and tminfected with Wamydia. Elementxy bodies of Chin- 
mu.& tluoresce apple greeq and measure 350 to 4M mn. 
Controls for ooaspecifk binding of immunoglobulii cooskted 
of air-dried sections of test samples (atherectomy, coronary 
artery or myocardial samples) incubated with antl’bodies 
against moux. immmogbbuIi0 (Ig). human IgG, human IgM, 
human C3c, human fibrin and human HLA-DR Slides were 
scored a5 positive only if the Ckknydio-sp&fic antibody 
stained organisms mea consistent with Chiamydio 
and no similar staining was observed with all control antibod- 
ies. Other positive stlining was usually limited to stainmg of 
entrapped histiies with HLA-DR within tbe atherectomy 
specimen. Organisms that stained positively were usually lc+ 
catd superficiauy in the atberedomy specimen. Rarely were 
they associated with atheroma@us debris (three cases). Usu- 
allysuchdebriswasindependentofthestainedstructures’I%e 
amolmtofstainiiwasgraded0ntbebasiioftheaumbet0f 
organisms as beii nmrkedJy positive (too numerous to count), 
positive (10 to 100) or rare (<lO/pIaque). The latter cases were 
considered equivucal. AU cases were reviewed by an expeti- 
eiredpath0lo@whowasuninf0rmedoftbeclinigtciramt- 
stancesatthetime0freview.Slides0fthepreparationwere 
~~~~~~~~l~a~~ 
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ofmmllR?ylddneyeenshlfinfeded 
withcThhmy&speeiesreaetedwitll~agaimtcMmn)riip 
altiptllatisflwn%eiiisothiayitoatelabekd.Tllepr~is 
simuttaneuusly mated with 0.016% Evans biue puwder, WWI staim 
nudeiofcellsredThe~uti~~cattaimmethylafeMueasa 
axutterstain. Tote organ&c; appear as appk green dctz Tk- @crc 
was exposed fur 15 s. x22-10, reduced by 32%. 
with organisms found extensively within the atherusclerotic 
plaque, and Figure 3 sbvs a plaque \n:Ctoot nrganislns 
Tmnsmission elecbvn microsc~. Transmission electron 
mboscopy was used to confirm the presence of appropriate 
C&my&r organisms in five of the specimens staining positive 
by immunofluorescence. Tissues were fued with Gmov&y’s 
ghttamtdehyde-parafonnaldehyde followed by fisatinn in 1% 
osmium tetroxide. Specimens were embedded m Epon (Ernest 
F. Fullman), thin-sectioned, stained with many1 acetate and 
Fii2. Frozenrcctionofmmnatyatherectomypkquereactedwith 
antibodyagainstRuoIesceinkothiocyanate-khel~antigen. 
Alargentunberoforganbsareseen,mmeofwitichareinaggre 
gates. No au- atheromatollsdebtiswaspresentintbis 
re-gim.-stainedwithotheratl~werenega~.nte 
.K!UbtliSO~teliItSrparbedfypnritive~~1Ss.X254 
E&C-d@34%. 
3.seuiondsthemderoticplaqueinntrichlloabaaipmJaIe 
found.Tttisrvarstainedande+tedemctfyarF~1aud2 
Becamenuurganmnwmfeund,tbespecimmw&itnerpretedas 
negative.EspuretimeI5s.x1oO,reducedby34%. 
lead citrate and examined in a JEOL 1tXB transmissinn 
electron microscope. 
Data rolketien ami ttnaly& For each atherectomy and 
control transplant pat&& routine denmgrapb and clinieal 
data were pmspc&c$ cntcrcd inb a data bank. A!! data vvcre 
verified by retrospective review of patient records. Data are 
presented as prc;~rtions or means and SD for cuntinuw; 
variables. Fur atherectomy patients, &variate analysis was 
petfortned on all clinical variables to determine possible 
corretatioas between patient dinical and tissue chatacteristics 
Statistical compahm were performed using chi-quare sta- 
tistic or, when appropriate, the Fisher exact test, for categoricaf 
and Student I test for amtinuws variabks A p value <0.05 
was c5nsidered sigllificatlt. 
ksuYs 
Demopphic data for the atherusckrotic patiems under- 
goingcoronatyathetectomyasweUasthehearttratt+nt 
patients with nonathemsckratic auonary disease are listed in 
TaMe1.ThecmJysigniScantditTerencenntedintheha.sekue 
tdinkal chatacteristics between the twu puplllatilms Pas the 
ittckha of a positive famify history of coronary artery t&ease 
which was presalt in 578 of athereclomypatieaLr lTampad 
wilhotlly251intran+mreripiell4althougll*nltntbers 
oftran@autre~tswereslnail. 
TaMe2stmwstheresultsofimmunufltmmscence te-+g for 
CI7kqdaspecicsittatheroscleroticandanttml~espeei- 
tuen~~Atntidof9Dwrnnaryattterectnmyand24cantrnJ 
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Table 1. Demographic Data of Patients Undergoing Athercctomy and Cbnirol Transplant Recipients 
Atherecromy (n = W) Transplant (n = 12) p Value 
2 (yr) (median. Zth-75th percentiles) 57, SO-65 58, so-66 0.48 
P 87% 83% II.44 
Atherosckrotic risk fackrs 
Systemic ltypertension 51% 175 0.07 
Diabetes mellihls 14% 0% 0.28 
Hypercholesterolemia 49% 42% 0.59 
Family history of CAD 57% 2.5% 0.03 
Ciiarette smoking 46% 42% 0.65 
hdication for pm&w NA 
stable angina 18% NA 
Unstable angina 44% NA 
Post-myocardial infarction 38% NA 
Resteaotic lesion 17% NA 
Multivessel disease 37% NA 
Vessel inwlwd NA 
L4D 51% NA 
Lcx 10% NA 
RCA 324 NA 
LMCA 1% NA 
Sapbeaous rein graft 6% NA 
Positioa in vewl 
Ft.oxialal 64% NA 
Mid&e 29% NA 
D&al 7% NA 
CAD = ccmaary artery diiase; LAD = leli anterior descending coronary artery; LCX = left circumflex coronary 
amy; LMC.4 = left main coroaq artery; NA = sot applicable; RCA = right coronary artery. 
coronary specimens showed any evidence of Chlnmjriia. The 
statistical .Ggdcme of this Merence is a p value <O.OOl . 
microscopy. These samples usually represented 10% to 25% of 
the sample used for immunotluorescence. 
Fiie 8pecimins staining positive for CMatnydk by immune- Ciinkal txr&tia~. The clinical and angiograpbic ctxx- 
tluorescenee were exan&d by transmission electron micros- acteristics and related u&variate predictors CL a posit& ~lr~ue 
copy (see Fii 4). In three cases structures similar in morphol- test for Ch&my& spcies in atherectomy specimens are !hed 
ogy and size to ChLunydia were found within the atherectomy in Table 3. Clinical factors of age, male gender, smoking, 
material. Both in&u&n-like st~clwes containing round and hyperliprdemia, hypertension, diabetes, positive family medii 
pear-shaped structures siiar to Cwnmydi reticulate bodies history, unstable angina and post-myocardial infarction status 
and elementary bodii respectively. and free pear-shaped dii not signikantly affect the incidence of a positive tissue test 
pnrklcs were found. The s&e of the elementary bodies was for Chlamyak. Angiographic factors of multivessel disease and 
~edatclosetoO~Ulun,whichissimiiarinsizetothose treatment of a saphenous vein graft likewise were not predic- 
seen in cell culture (18). Organisms were found attached to tive of the presence of Chbnydia. The only nearly significant 
debris but not within entrapped macrophages within the predictor of the presence of Chlumydia within the tissue 
pbques. Tht: la& of organisms in two of the positive samples specimen was whether the sample originated from a primary or 
relates to the small size of the samples used for electron restenotic coronary lesion. Restenotic vessels accounted for 
T&k 2 Results of Direct hnmunotluorescence for Chlom$a Speck on Atheroscierok and 
Norm-cspecimem 
kveldspechmStainingforChlnmydiospecies 
Specimc~Tlpe hfarkedlypositive lbsitiw, Equivocal Negative ._____ 
7 (8%) 59(65%) 5 (6%) 19(21%) 
(n=!Jo) 
- 12(100%) 
cisw(n=12) 
bIormdmIoaatytisaae(o = 12) - - 1 (8%) I1 mb) 
l!nCatiate 
OddsRatio pvahK 
I.44 0.56 
1.3s 0.62 
1.3 0.a 
Lot 0.95 
I .a1 1.00 
O.!N 0.85 
052 OM 
0.45 03 
039 030 
033 0.06 
029 0.22 
- 0.49 
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FI~UE A Transmission electron microscope image of a chlamydial 
organism found within a positively staining atherectomy specimen. II is 
seen directly beneath the dark armw&d. IXe small dark central 
“elementary body” can be seen surrounded by a membranous strut- 
ture. Other organism-like structures are seen nearby. The organism is 
not within a cell, although fragments of cells (C) can be seen. Collagen 
fibrils and e&in surround the cell fragments and organism. ~37,500, 
reduced by 35%~ 
32% of negative but only 13% of positive specimens, resulting 
in an odds ratio of 0.33 (p = 0.06). Neither the specific native 
coronary artery involved nor the position of the lesion within 
the vessel was predictive of the presence of CWamy&z. 
Discussion 
To our knowledge, this is the first report of the differential 
incidence of CM~rnydia species within the coronary artery wall 
of patients with atherosclerosis versus those with other forms 
of cardiovascular disease. The extremely high rate of possible 
infection in patients with symptomatic atherosclerotic disease 
(79%) compared to the very low rate in patients with normal 
coronary arteries or coronary artery disease from chronic 
transplant rejection (4%) provides new evidence for a direct 
link between the atherosclerotic process and Chlant~diu infec- 
tion. If Chhmzydia were to be present only as an “innocent 
bystander,” finding fertile ground to grow within the diseased 
atherosclerotic arterial wall, it should also be found within the 
walls of arteries diseased by processes other than atheroscle- 
rosis. The process of accelerated coronary artery disease 
associated with chronic cardiac transplant rejection is very 
similar histologically to atherosclerosis {is) but IS believed to 
result from an immunologic mechanism different from that of 
atherosclerosis (20). This absence of Chlamydia infection 
within diseased coronary segments of transplanted hearts 
appears to increase the likelihood that Ch/mnyiiu plays an 
active role in the pathogenesis of natural atherosclerosis. The 
absence of Chlamvdia within native coronary arteries in 21% of 
patients suggests that other factors may be involved in some 
cases, that Chlamydio infection (once present) has resolved, or 
that, as postulated by Kuo et al. (14). because of the small 
quantity of tissue (on average 185 mg 1211) in samples tested, 
the study is limited by the sensitivity of the technique. It is 
therefore possible that, @en an appropri~e!y semi!ive test, 
chlamydial infection may be present in an even higher percent- 
age of patients with symptomatic coronary atherosclerotic 
disease. However, because a history of chlamydial infection is 
so prevalent in the population (50% of subjects are exposed by 
middle age [22]). the issue of causality remains. 
How might the colonization of the arterial wall with C/&z- 
mydia species contribute to ihe &velopment of atherosclerosis 
and ischemic coronary heart disease? On a physiologic and 
pathologic level, abnormal interactions among endothelial 
cells, platelets, macrophages and l,ympho+s may lead to a 
cascade of events resulting in acute endothelial damage. 
thrombosis and repair, chronically leading to the development 
of atheroma in blood vessels (23.24). it is known that tissue 
factor is a major inducer of thrombus formation. In blood 
vessels that are injured. stimulated endothelial cells exhibit 
increased tissue factor procoagulant activity that promotes 
thrombosis and platelet adhesion at the site of injury, which in 
turn may promote the development of atherosclerosis (25). 
Infection by Chlomqdia pwmniae has been shown to pro- 
duce a similar effect. In studies performed hy Fryer et al. (26). 
Chlamyd~ pneumotrtie was made to infect human umbilical 
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arterial endothelial cells and produced an increase in tissue 
factor procoagulant activity of 4 to 13 times over the control 
level. Additionally, Cwnrnydia pneumoniae-infected cells were 
shown to enhance platelet adhesion compared with nonin- 
fected control cells. It is therefore feasible that these or other 
as yet undetermined physiologic effects of Chkrntydk pneu- 
moniec infection of arterial tissues may play a significant role 
in the initiation and progression of coronary atherosclerosis. 
As in any possible infection, in order to establish a direct 
etiologic link between the disease process and the infecting 
agent, a series of tests must be performed to satisfy the criteria 
that have come to be known as “Koch’s postulates” (27). 
Under these rules, the microorganism, to be pathologic, must 
be present in all or nearly all cases of the disease, inoculations 
of its pure cultures must produce disease (for example, when 
injected into susceptible animals), and from these diseased 
organisms, it must again be able to be obtained and be 
propagated in pure cultures. Of these, the first postulate 
appears to be true with Ch!mydia species and atherosclerotic 
coronary heart disease. 
~Iknltntions. This prospective study provides a convincing 
association between Chlmydk infection and coronary athero- 
sclerosis. The presence of a series of negative controls of 
coronary arteries with diseased intima, but from mechanisms 
other than atherosclerosis, further strengthens that associa- 
tion. However, several limitations do exist in this study. First, 
specimens were so small that sampling error may be present in 
the specimens negative for the presence of bacteria. Second, 
because these specimens came from a somewhat select popu- 
lation of patients, namely those $tb coronary lesion charac- 
teristics suitable for referral for coronary atherectomy, they 
may not be totally representative of the overall population of 
patients with coronary atherosclerosis. Third, this study still 
does not define a definite etiologic role for CMrnrydkr infection 
in the development of coronary atherosclerosis, and this will 
require further studies. It is still possible that atherosclerotic 
plaque is merely a more fertile ground for Chhmydia to be 
deposited and grow. If this were the case, the presence of the 
pathogens would be a result rather than a cause. Viability of 
the bacterial elements also needs to be confumed through 
successful cultures, althou:& this has proven to be ditllcult. 
Animal models need to be developed that will allow for the 
careful study of the pathopbysiology of coronary arterial 
infections Fourth, the precise speciation of Ch&unydia will 
require further study. However, our preliminary identilkation 
of Chlomydio pnenmoniac strain T?VAR by polymerase chain 
reaction in two specimens is consistent with other reports that 
associate this straio with atherosclerosis (17). Finally, large 
tarnlomized clinkal trials of antibiotic treatment or prophy- 
laxis will be required to determine any effect on patient 
outcome. 
CaneIosinna. Positive or equivocal evidence for the pres- 
enceofCMznr@waspresentin79%ofathero&rotic 
specirneos tested. In cot&* evidence of C&!tun+ was 
fouodinonly4%ofthecontrolnowala#onaryspecirnensor 
~~~~~~~f~of~ 
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nary artery disease. This high incidence of Chhmydia only in 
coronary arteries diseased by atherosclerosis as compared to 
other forms of coronary disease provides evidence for an 
etiologic role of Chlumydia infection in the development of 
coronary atherosclerosis. Further studies are required to con- 
firm all of Koch’s postulates concerning this hypothesis. 
Wr thank Janet K Hansen, Louise S. Spencer and Ann 0. Jensen for their 
technical expertise with direct immunofluorescence examinations. 
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